{"description":"All Treated Population included all participants who received at least one dose of study treatment.","eventGroups":[{"deathsNumAffected":2,"deathsNumAtRisk":6,"description":"Participants were administered 2.5 mg/kg of belantamab mafodotin in combination with 200 mg of pembrolizumab via intravenous (IV) infusion on Day 1 of each 21-day Cycle up to until disease progression, intolerable toxicity, informed consent withdrawal , or for a maximum of 35 cycles.","id":"EG000","otherNumAffected":6,"otherNumAtRisk":6,"seriousNumAffected":4,"seriousNumAtRisk":6,"title":"Main Study Phase- Part 1: Belantamab Mafodotin 2.5 mg/kg + Pembrolizumab 200 mg Escalation"},{"deathsNumAffected":3,"deathsNumAtRisk":7,"description":"Participants were administered with 3.4 mg/kg of belantamab mafodotin in combination with 200 mg of pembrolizumab via IV infusion on Day 1 of each 21-day Cycle up to until disease progression, intolerable toxicity, informed consent withdrawal, or for a maximum of 35 cycles.","id":"EG001","otherNumAffected":6,"otherNumAtRisk":7,"seriousNumAffected":5,"seriousNumAtRisk":7,"title":"Main Study Phase- Part 1: Belantamab Mafodotin 3.4 mg/kg + Pembrolizumab 200 mg Escalation"},{"deathsNumAffected":7,"deathsNumAtRisk":28,"description":"Participants were administered belantamab mafodotin with recommended phase 2 dose (RP2D) of 2.5 mg/kg in combination with 200 mg of pembrolizumab via IV infusion on Day 1 of each 21-day Cycle up to until disease progression, intolerable toxicity, informed consent withdrawal, or for a maximum of 35 cycles.","id":"EG002","otherNumAffected":27,"otherNumAtRisk":28,"seriousNumAffected":5,"seriousNumAtRisk":28,"title":"Main Study Phase- Part 2: Belantamab Mafodotin 2.5 mg/kg + Pembrolizumab 200 mg Expansion"},{"deathsNumAffected":0,"deathsNumAtRisk":2,"description":"Participants who completed approximately 178 weeks of treatment of 2.5 mg/kg belantamab mafodotin in combination with 200 mg of pembrolizumab via IV infusion had the opportunity to continue receiving belantamab mafodotin in the PACT phase up to approximately 221 weeks.","id":"EG003","otherNumAffected":0,"otherNumAtRisk":2,"seriousNumAffected":0,"seriousNumAtRisk":2,"title":"PACT Phase- Belantamab Mafodotin 2.5 mg/kg + Pembrolizumab 200 mg"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":6,"numEvents":5},{"groupId":"EG001","numAffected":3,"numAtRisk":7,"numEvents":3},{"groupId":"EG002","numAffected":5,"numAtRisk":28,"numEvents":5},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":3},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":4},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":5},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6,"numEvents":4},{"groupId":"EG001","numAffected":3,"numAtRisk":7,"numEvents":6},{"groupId":"EG002","numAffected":9,"numAtRisk":28,"numEvents":10},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Thrombocytopenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6,"numEvents":7},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Blepharitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6,"numEvents":4},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":4,"numAtRisk":28,"numEvents":4},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Dry eye"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Eye pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":6,"numEvents":7},{"groupId":"EG001","numAffected":6,"numAtRisk":7,"numEvents":7},{"groupId":"EG002","numAffected":20,"numAtRisk":28,"numEvents":27},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Keratopathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":3,"numAtRisk":28,"numEvents":3},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Photophobia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6,"numEvents":4},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":10,"numAtRisk":28,"numEvents":10},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Vision blurred"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6,"numEvents":3},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":7,"numAtRisk":28,"numEvents":7},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":3,"numAtRisk":28,"numEvents":3},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6,"numEvents":9},{"groupId":"EG001","numAffected":3,"numAtRisk":7,"numEvents":5},{"groupId":"EG002","numAffected":3,"numAtRisk":28,"numEvents":3},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":4,"numAtRisk":7,"numEvents":4},{"groupId":"EG002","numAffected":10,"numAtRisk":28,"numEvents":12},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":3},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":7,"numAtRisk":28,"numEvents":7},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Infusion related reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":3,"numAtRisk":28,"numEvents":3},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":4,"numAtRisk":28,"numEvents":4},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":2},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":5},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Visual acuity tests abnormal"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Weight decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Hypokalaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Hypomagnesaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":3,"numAtRisk":28,"numEvents":3},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Musculoskeletal chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":4},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pain in extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":3},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":6,"numEvents":3},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":3},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":3},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":3},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Epistaxis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Hypertension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Febrile neutropenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Atrial flutter"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Cardiac failure congestive"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Cardiopulmonary failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Large intestinal haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Chest pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Anaphylactic reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Cytokine release syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Bacteraemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Leishmaniasis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":2},{"groupId":"EG002","numAffected":4,"numAtRisk":28,"numEvents":6},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pneumonia haemophilus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":6,"numEvents":2},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Femur fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":2,"numAtRisk":28,"numEvents":2},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Infusion related reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Subdural haematoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Platelet count decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Hypoglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":6,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Basal cell carcinoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Plasmacytoma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Mental status changes"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Acute kidney injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Renal failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"Meddra v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":0,"numAtRisk":7,"numEvents":0},{"groupId":"EG002","numAffected":1,"numAtRisk":28,"numEvents":1},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Hypoxia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA v24.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":6,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":7,"numEvents":1},{"groupId":"EG002","numAffected":0,"numAtRisk":28,"numEvents":0},{"groupId":"EG003","numAffected":0,"numAtRisk":2,"numEvents":0}],"term":"Pyrexia"}],"timeFrame":"All-cause mortality, non-serious adverse events (non-SAEs) and serious adverse events (SAEs) were collected from day 1 to week 178 for Main Study Phase and from week 178 to week 221 for PACT phase."}